Aberrant intermediate alveolar epithelial cells promote pathogenic activation of lung fibroblasts in preclinical fibrosis models
Evan T. Hoffman(University of Pennsylvania), Jeremy Katzen(Translational Therapeutics (United States)), Micha Sam Brickman Raredon(Yale University), Pushpinder Bawa(Boston University), L. Raposo Rodríguez(California University of Pennsylvania), Adam Bennett(Pulmonary and Allergy Associates), Darrell N. Kotton(Boston University), Aditi Murthy(Pulmonary and Allergy Associates), Yaniv Tomer(University of Pennsylvania), Feiya Wang(Boston University), Apoorva Babu(University of Pennsylvania), Maria C. Basil(Boston University), Katrina Chavez(Pulmonary and Allergy Associates), Konstantinos–Dionysios Alysandratos(Boston Medical Center), Dakota L. Jones(Boston University), Anit Shah(University of Pennsylvania), Lauren J. Ayers(Boston University), Rachna Dherwani(Pulmonary and Allergy Associates), A. Lange(Boston University), Charlotte H. Cooper(Pulmonary and Allergy Associates), Kasey Minakin(Boston University), Porter E. Dooley(Boston University), Willy Roque Barboza(Pulmonary and Allergy Associates)
Cited by 13
Related Papers
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
|Nature reviews. Immunology|2015|758
The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future
|Cell stem cell|2020|419
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
|Cancer Immunology Research|2015|332